Italy’s Angelini Said to Explore Acquisition of Catalyst Pharma
Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.
By Manuel Baigorri, Dinesh Nair, Daniele Lepido · Bloomberg
Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.